Metraipolis › archive › dc_f7987be49931

LYSG101: a potent chimeric lysin with therapeutic potential for combating Staphylococcus aureus infections — Europe PMC PMID:42059658

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42059658
DOI
10.1128/aac.01730-25
License (as archived)
solo-consultazione
Archived
2026-11-03T01:27:44.275Z
SHA-256 of the archived text
7d918f4e48d65b66338654d4a216e52d11bfec94e65ce9b54873fefd2d3331bf
Stable URL of this page
https://metraipolis.com/documento/dc_f7987be49931

How to cite

LYSG101: a potent chimeric lysin with therapeutic potential for combating Staphylococcus aureus infections — Europe PMC PMID:42059658 — Europe PMC (en), https://europepmc.org/article/MED/42059658 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f7987be49931 (Metraipolis archive dc_f7987be49931, sha256 7d918f4e48d65b66338654d4a216e52d11bfec94e65ce9b54873fefd2d3331bf)
BibTeX
@misc{dcf7987be49931,
  title = {LYSG101: a potent chimeric lysin with therapeutic potential for combating Staphylococcus aureus infections — Europe PMC PMID:42059658},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42059658},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f7987be49931; sha256 7d918f4e48d65b66338654d4a216e52d11bfec94e65ce9b54873fefd2d3331bf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42059658. Agents can read the archived copy with the MCP tool read_document.